NFIL3 was described as part of an enhancer hotspot associated gene in NASH-prone livers [47] and mechanistically affects gluconeogenesis in hepatocytes [48, p. 3] and lipid accumulation [49]. Here, NFIL3 is linked to metabolic dysfunction-associated steatohepatitis.